Mechanisms linking adenosine A1 receptors and extracellular signal-regulated kinase 1/2 activation in human trabecular meshwork cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 320, Issue 1, 2007, Pages 258-265

  Husain, S ^a   Shearer, T W ^a,b   Crosson, C E ^a,c  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b ALCON RESEARCH LTD   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 1,4 DIHYDRO 2 METHYL 6 PHENYL 4 (2 PHENYLETHYNYL) 3,5 PYRIDINEDICARBOXYLIC ACID 5 BENZYL 3 ETHYL ESTER; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 AMINO 7 TERT BUTYL 5 (4 CHLOROPHENYL)PYRAZOLO[3,4 D]PYRIMIDINE; 8 CYCLOPENTYLTHEOPHYLLINE; ADENOSINE A1 RECEPTOR ANTAGONIST; CYCLOHEXYLADENOSINE; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PERTUSSIS TOXIN; PROTEIN KINASE C; RAS PROTEIN;

ARTICLE; CELL CULTURE; CELL LINE; CONTROLLED STUDY; CYTOSOL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TRABECULAR MESHWORK; WESTERN BLOTTING;

ADENOSINE; CELLS, CULTURED; ENZYME ACTIVATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; PHOSPHOLIPASE C; PROTEIN KINASE C; RECEPTOR, ADENOSINE A1; RNA, SMALL INTERFERING; TRABECULAR MESHWORK;

EID: 33845891369     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.110981     Document Type: Article

References (30)

1. Alexander JP and Acott TS (2001) Involvement of protein kinase C in TNFalpha regulation of trabecular matrix metalloproteinases and TIMPs. Investig Ophthalmol Vis Sci 42:2831-2838.
2. Alexander JP and Acott TS (2003) Involvement of the Erk-MAP kinase pathway in TNFalpha regulation of trabecular matrix metalloproteinases and TIMPs. Investig Ophthalmol Vis Sci 44:164-169.
3. Alonso A, Sasin J, Bottini N, Friedberg I, Friedberg I, Osterman A, Godzik A, Hunter T, Dixon J, and Mustelin T (2004) Protein tyrosine phosphatases in the human genome. Cell 117:699-711.
4. 3-subtype adenosine receptors modulate intraocular pressure in the mouse. Br J Pharmacol 134:241-245.
5. Crosson CE (1995) Adenosine receptor activation modulates intraocular pressure in rabbits. J Pharmacol Exp Ther 273:320-326.
6. Crosson CE (2001) Intraocular pressure responses to the adenosine agonist cyclohexyladenosine: evidence for a dual mechanism of action. Investig Ophthalmol Vis Sci 42:1837-1840.
7. Crosson CE and Gray T (1994) Modulation of intraocular pressure by adenosine agonists. J Ocul Pharmacol 10:379-383.
8. 6-cyclohexyladenosine. Investig Ophthalmol Vis Sci 46:3795-3799.
9. Daines BS, Kent AR, McAleer MS, and Crosson CE (2003) Intraocular adenosine levels in normal and ocular-hypertensive patients. J Ocular Pharmacol Ther 19:113-119.
10. Ducruet AP, Vogt A, Wipf P, and Lazo JS (2005) Dual specificity protein phosphatases: therapeutic targets for cancer and Alzheimer's disease. Annu Rev Pharmacol Toxicol 45:725-750.
11. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, and Tuschl T (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (Lond) 411:494-498.
12. Fleischhauer JC, Mitchell CH, Stamer WD, Karl MO, Peterson-Yantorno K, and Civan MM (2003) Common actions of adenosine receptor agonists in modulating human trabecular meshwork cell transport. J Membr Biol 193:121-136.
13. Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, and Linden J (2001) International Union of Pharmacology: XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527-552.
14. Gabelt BT and Kaufman PL (2005) Changes in aqueous humor dynamics with age and glaucoma. Prog Retin Eye Res 24:612-637.
15. Nishizuka Y (1988) The molecular heterogeneity of protein kinase C and its implications for cellular regulation. Nature (Lond) 334:661-665.
16. Pang IH, Shade DL, Clark AF, Steely HT, and DeSantis L (1994) Preliminary characterization of a transformed cell strain derived from human trabecular meshwork. Curr Eye Res 13:51-63.
17. Pearson G, Robinson F, Beers-Gibson T, Xu BE, Karandikar M, Berman K, and Cobb MH (2001) Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153-183.
18. Ralevic V and Burnstock G (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50:413-492.
19. Roth S, Rosenbaum PS, Osinski J, Park SS, Toledano AY, Li B, and Moshfeghi AA (1997) Ischemia induces significant changes in purine nucleoside concentration in the retina-choroid in rats. Exp Eye Res 65:771-779.
20. Roux PP and Blenis J (2004) ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68: 320-344.
21. Schulte G and Fredholm BB (2002) Diverse inhibitors of intracellular signalling act as adenosine receptor antagonists. Cell Signal 14:109-113.
22. Schulte G and Fredholm BB (2003) Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal 15:813-827.
23. Shah BH, Baukal AJ, Shah FB, and Catt KJ (2005) Mechanisms of extracellularly regulated kinases 1/2 activation in adrenal glomerulosa cells by lysophosphatidic acid and epidermal growth factor. Mol Endocrinol 19:2535-2548.
24. Shearer TW and Crosson CE (2001) Activation of extracellular signal-regulated kinase in trabecular meshwork cells. Exp Eye Res 73:25-35.
25. Shearer TW and Crosson CE (2002) Adenosine A1 receptor modulation of MMP-2 secretion by trabecular meshwork cells. Investig Ophthalmol Vis Sci 43:3016-3020.
26. i protein-coupled receptor. EMBO (Eur Mol Biol Organ) J 18:386-395.
27. Tegeder I and Geisslinger G (2004) Opioids as modulators of cell death and survival: unraveling mechanisms and revealing new indications. Pharmacol Rev 56:351-369.
28. Thieme H, Nass JU, Nuskovski M, Bechrakis NE, Stumpff F, Strauss O, and Wiederholt M (1999) The effects of protein kinase C on trabecular meshwork and ciliary muscle contractility. Investig Ophthalmol Vis Sci 40:3254-3261.
29. Tian B, Gabelt BT, Crosson CE, and Kaufman PL (1997) Effects of adenosine agonists on intraocular pressure and aqueous humor dynamics in cynomolgus monkeys. Exp Eye Res 64:979-989.
30. Walsh MP, Andrea JE, Allen BG, Clement-Chomienne O, Collins EM, and Morgan KG (1994) Smooth muscle protein kinase C. Can J Physiol Pharmacol 72:1392-1399.